Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Platelet transfusion therapy: from 1973 to 2005.

Anneke Brand1, Vera Novotny, Bert Tomson

  • 1Department of Immunohematology and Blood Transfusion, Leiden University Medical Center, the Netherlands. anneke.brand@bloodrtd.nl

Human Immunology
|May 27, 2006
PubMed
Summary

Platelet transfusions have significantly improved for patients with blood disorders. Innovations have made platelet products safer, more available, and longer-lasting, enhancing patient care.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Perceptions of deferred blood donors regarding false-positive screening results for infectious diseases and European blood establishment strategies.

Vox sanguinis·2025
Same author

Anti-D immunization after D positive platelet transfusions in D negative recipients: A systematic review and meta-analysis.

Transfusion·2024
Same author

The EHA Research Roadmap: Transfusion Medicine.

HemaSphere·2022
Same author

Medical student education in transfusion medicine, part II: Moving forward to building up a "Know How" education program in transfusion medicine for under-graduate medical students.

Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis·2020
Same author

Prevalence of red-blood-cell and non-red-blood-cell-targeted autoantibodies in alloimmunized postpartum women.

Vox sanguinis·2020
Same author

Ensuring HLA-matched platelet support requires an ethnic diverse donor population.

Transfusion·2020

Area of Science:

  • Hematology
  • Transfusion Medicine
  • Immunology

Background:

  • Historically, supporting patients with allo-antibodies against human leukocyte antigens (HLA) during platelet transfusions was challenging and often unsuccessful.
  • Platelet transfusions are critical for managing hematological diseases and preventing bleeding complications.

Observation:

  • Significant advancements in platelet product development have occurred since the 1970s.
  • Current platelet transfusions exhibit low immunogenicity and are readily available.
  • Platelet products now have an extended shelf life of up to 7 days.

Findings:

  • Innovations have led to routine availability of matched platelets through improved communication across the transfusion chain.
  • Stepwise innovations have enhanced the safety and efficacy of platelet transfusions.

Related Experiment Videos

  • Current platelet products are characterized by low immunogenicity and sufficient availability.

    • Implications:

    • Future enhancements may include uniform type and screen methods for immunized patients and computer-assisted cross-matching.
    • Sharing typed donor files between blood banks and stem cell donor banks can optimize healthcare resource utilization.
    • Continued innovation promises further improvements in platelet transfusion therapy for complex patient populations.